monoclonal antibody (Zhejiang Jingxin Pharmaceutical)
N/A
Report date: 2025/01/26 18:24:40
Base Information
Drug Namemonoclonal antibody (Zhejiang Jingxin Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A